Fundraising Fox
🦊/People
Sign in

Jake Bauer

Investor

Manager, Entrepreneur Programs at Rev1 Ventures · Venture Partner at SR One Capital Management · Board director at Simcha Therapeutics

San Francisco Bay Area

Find your path to Jake

792 people in our graph share verified history with Jake — schools, employers, funds. One of them is your warm intro.

Krishna YeshwantunlockedJake: together at Harvard Business School (2007)
×3Jake: together at Harvard Business School
Jake: together at SR One Capital Management
Jake: together at Rev1 Ventures

About

Jake Bauer is a Venture Partner at SR One who works with emerging clinical biotechnology companies. He previously served as Chief Business Officer of MyoKardia, which was acquired by Bristol Myers Squibb in 2020, and held earlier roles at Ablexis, Third Rock Ventures, Royalty Pharma, Endo Pharmaceuticals, and Putnam Associates. He holds a BS in Biology and BA in Economics from Duke University and an MBA from Harvard Business School.

Contact· self-published, not guessed

Invests in

Biotech

Board director at Simcha Therapeutics

Intro paths

→

In turn, Jake can intro founders to Simcha Therapeutics's investors below.

Simcha Therapeutics's investors · 7

Axial VCSan Francisco · $100K – $5M checksBiotechnology Value FundSan Francisco · since 2022Connecticut InnovationsNew Haven · $500K – $2M checksPfizer Venture Investments$5M – $20M checksRock Springs CapitalBaltimore · since 2022Samsara BioCapitalPalo Alto · since 2022SR One Capital ManagementRedwood City · since 2022

Co-founders at Simcha Therapeutics

ARAaron Ring
Aaron RingExecutive Officer, Director

Experience

  1. ImmunovantMember Board of Directorscurrent2025 — present
  2. BBOTChair of the Board of Directorscurrent2025 — presentSouth San Francisco, CA
  3. Simcha TherapeuticsChairman of the Boardcurrent2022 — presentUnited States
  4. SR One Capital ManagementVenture Partnercurrent2021 — present
  5. ARCH Venture PartnersVenture Partnercurrent2021 — present
  6. AttralusMember Board Of Directorscurrent2021 — presentSouth San Francisco, California, United States
  7. Enliven TherapeuticsChair of the Board of Directorscurrent2021 — presentBoulder, CO
  8. ARYA Sciences Acquisition Corp VMember Board Of Directors2021 — 2023
  9. Phoenix Tissue Repair, Inc.Member Board Of Directors2018 — 2022
  10. Bristol Myers SquibbConsultant & Integration Lead, Enterprise Integration Management2020 — 2021Brisbane, California, United States
  11. MyoKardiaChief Business Officer2018 — 2020South San Francisco, California, United States
  12. MyoKardiaSVP, Finance and Corporate Development2014 — 2017South San Francisco, California, United States
  13. Arya Sciences Acquisition Corp IIMember Board Of Directors2020
  14. Ablexis, LLCVP, Business Operations & Head of Corporate Development2011 — 2014San Francisco Bay Area
  15. Third Rock VenturesPrincipal2007 — 2011Boston, MA and San Francisco, CA
  16. Royalty PharmaAssociate2006
  17. Endo PharmaceuticalsBusiness Development2006
  18. Putnam AssociatesSenior Associate2001 — 2005

Investments

Board seats

Arya Sciences Acquisition Corp VAttralusEnliven TherapeuticsPhoenix Tissue Repair, Inc.

Per the firm's website.

Colleagues at Rev1 Ventures

Alicia Oddi
Managing Director, Venture Services at Rev1 Ventures
Amy Taylor
Board of Directors; President, Downtown Columbus, Inc. at Rev1 Ventures
Amy Whetsell
Executive Administrator at Rev1 Ventures
Andrea Ewing
Director, Corporate Partnerships at Rev1 Ventures
Andrea O'Carroll
Managing Director, Venture Platform at Rev1 Ventures
Andrea O’Carroll
Managing Director, Venture Platform at Rev1 Ventures
Avi Jayaraman
Seae Ventures Fellow at Seae Ventures
Brian Brohman
Life Sciences Advisory Partner at Rev1 Ventures

Frequently asked questions

Who is Jake Bauer?
Jake Bauer is a Venture Partner at SR One who works with emerging clinical biotechnology companies. He previously served as Chief Business Officer of MyoKardia, which was acquired by Bristol Myers Squibb in 2020, and held earlier roles at Ablexis, Third Rock Ventures, Royalty Pharma, Endo Pharmaceuticals, and Putnam Associates. He holds a BS in Biology and BA in Economics from Duke University and an MBA from Harvard Business School.
Where does Jake Bauer work?
Jake Bauer is Manager, Entrepreneur Programs at Rev1 Ventures and Board director at Simcha Therapeutics.
What does Jake Bauer invest in?
Jake Bauer invests in Biotech.
What boards does Jake Bauer sit on?
Jake Bauer holds tracked board seats at Arya Sciences Acquisition Corp V, Attralus, Enliven Therapeutics, Phoenix Tissue Repair, Inc..
Where did Jake Bauer go to school?
Jake Bauer studied at Harvard Business School (MBA); Duke University (BS Biology / BA Economics).

Same school

Shared employers